Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes

详细信息    查看全文

• 作者：Petra Hirsova¹ ; Samar H. Ibrahim² ; Anuradha Krishnan¹ ; Vikas K. Verma¹ ; Steven F. Bronk¹ ; Nathan W. Werneburg¹ ; Michael R. Charlton³ ; Vijay H. Shah¹ ; Harmeet Malhi¹ ; Gregory J. Gores¹ ; ^{gores.gregory@mayo.edu" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Exosomes ; Microvesicles ; Lipotoxic ; Cell Death
• 刊名：Gastroenterology
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：150
• 期：4
• 页码：956-967
• 全文大小：3088 K

文摘

Hepatocyte cellular dysfunction and death induced by lipids and macrophage-associated inflammation are characteristics of nonalcoholic steatohepatitis (NASH). The fatty acid palmitate can activate death receptor 5 (DR5) on hepatocytes, leading to their death, but little is known about how this process contributes to macrophage-associated inflammation. We investigated whether lipid-induced DR5 signaling results in the release of extracellular vesicles (EVs) from hepatocytes, and whether these can induce an inflammatory macrophage phenotype.

Methods

Primary mouse and human hepatocytes and Huh7 cells were incubated with palmitate, its metabolite lysophosphatidylcholine, or diluent (control). The released EV were isolated, characterized, quantified, and applied to macrophages. C57BL/6 mice were placed on chow or a diet high in fat, fructose, and cholesterol to induce NASH. Some mice also were given the ROCK1 inhibitor fasudil; 2 weeks later, serum EVs were isolated and characterized by immunoblot and nanoparticle-tracking analyses. Livers were collected and analyzed by histology, immunohistochemistry, and quantitative polymerase chain reaction.

Results

Incubation of primary hepatocytes and Huh7 cells with palmitate or lysophosphatidylcholine increased their release of EVs, compared with control cells. This release was reduced by inactivating mediators of the DR5 signaling pathway or rho-associated, coiled-coil-containing protein kinase 1 (ROCK1) inhibition. Hepatocyte-derived EVs contained tumor necrosis factor-related apoptosis-inducing ligand and induced expression of interleukin 1β and interleukin 6 messenger RNAs in mouse bone marrow–derived macrophages. Activation of macrophages required DR5 and receptor-interacting protein kinase 1. Administration of the ROCK1 inhibitor fasudil to mice with NASH reduced serum levels of EVs; this reduction was associated with decreased liver injury, inflammation, and fibrosis.

Conclusions

Lipids, which stimulate DR5, induce release of hepatocyte EVs, which activate an inflammatory phenotype in macrophages. Strategies to inhibit ROCK1-dependent release of EVs by hepatocytes might be developed for the treatment of patients with NASH.